Barclays’s Guardian Pharmacy Services GRDN Stock Holding History

Barclays’s Portfolio GRDN Stock Details GRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$140K	Sell	3,333 -1,501	-31%	-$58.1K	﹤0.01%	3898
2026 Q1	$182K	Sell	4,834 -30,351	-86%	-$992K	﹤0.01%	3746
2025 Q4	$1.06M	Buy	35,185 +7,212	+26%	+$204K	﹤0.01%	3392
2025 Q3	$734K	Buy	27,973 +2,075	+8%	+$49.5K	﹤0.01%	3565
2025 Q2	$552K	Buy	25,898 +16,964	+190%	+$383K	﹤0.01%	3707
2025 Q1	$190K	Sell	8,934 -4,275	-32%	-$87.7K	﹤0.01%	4070
2024 Q4	$268K	Sell	13,209 -5,291	-29%	-$109K	﹤0.01%	4168
2024 Q3	$311K	Buy	+18,500	New	+$312K	﹤0.01%	4062

Other funds holding GRDN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

VCM

Valiant Capital Management San Francisco, California $2.48B AUM 57.08% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Barclays's GRDN Position: Q2 2026 in Review

Barclays reduced its Guardian Pharmacy Services (GRDN) stake by 31% in Q2 2026, selling an estimated $58.1K and leaving 3,333 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #3898.

Barclays first reported a position in GRDN in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.06M in Q4 2025. 190 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

Barclays held 3,333 shares of Guardian Pharmacy Services worth $140K as of Q2 2026.
Barclays sold 1,501 Guardian Pharmacy Services shares in Q2 2026, an estimated $58.1K.
Guardian Pharmacy Services made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3898 holding.
Barclays first reported a position in Guardian Pharmacy Services in Q3 2024 and has held it in 8 quarters since.
Barclays's Guardian Pharmacy Services position peaked at $1.06M in Q4 2025.
190 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.